Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma (Experimental Hematology & Oncology, (2024), 13, 1, (14), 10.1186/s40164-024-00484-9)

  • Fangfang Yan
  • , Vivian Jiang
  • , Alexa Jordan
  • , Yuxuan Che
  • , Yang Liu
  • , Qingsong Cai
  • , Yu Xue
  • , Yijing Li
  • , Joseph McIntosh
  • , Zhihong Chen
  • , Jovanny Vargas
  • , Lei Nie
  • , Yixin Yao
  • , Heng Huan Lee
  • , Wei Wang
  • , John Nelson R. Bigcal
  • , Maria Badillo
  • , Jitendra Meena
  • , Christopher Flowers
  • , Jia Zhou
  • Zhongming Zhao, Lukas M. Simon, Michael Wang

Research output: Contribution to journalComment/debatepeer-review

Abstract

After online publication of the article [1], the authors notified that Figure S9C in the published version does not appear as intended. Unfortunately, this discrepancy was not identified during the production process. Specifically, the current version of Figure S9C displays identical western data for both JeKo and Mino cell lines, which is incorrect. Published version and correct version of the supplementary Figure S9c is given below: Published version Correct version.

Original languageEnglish (US)
Article number19
JournalExperimental Hematology and Oncology
Volume15
Issue number1
DOIs
StatePublished - Dec 2026

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma (Experimental Hematology & Oncology, (2024), 13, 1, (14), 10.1186/s40164-024-00484-9)'. Together they form a unique fingerprint.

Cite this